COVID-19

Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe

SHANGHAI, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…

1 year ago

Sapphire Pharma Announces Groundbreaking New Treatment for Malaria with Revolutionary Technology

Sapphire Pharma Chairman & CEO Ramu Veerappan to Speak at World Economic Forum 2025Davos, Switzerland--(Newsfile Corp. - January 19, 2025)…

1 year ago

XORTX Announces Change of Auditor

CALGARY, Alberta, Jan. 17, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX…

1 year ago

Moderna Announces Updates on Pandemic Influenza Program

CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S.…

1 year ago

How Growing Number of Industries are Leveraging Artificial Intelligence to Create Lucrative Revenue Opportunities

FN Media Group News Commentary  PALM BEACH, Fla., Jan. 17, 2025 /PRNewswire/ -- The healthcare industry is rapidly integrating artificial intelligence (AI)-powered solutions…

1 year ago

National Inventors Hall of Fame Announces Vaccine and Surfboard Innovators Among 2025 Class

Honorees' Contributions to Society Are Centerpiece of May Event NORTH CANTON, Ohio, Jan. 15, 2025 /PRNewswire/ -- Seventeen innovation pioneers…

1 year ago

Aptevo’s Peter Pavlik, PhD, Chairing Session on “Bi and Multispecific Biologics” at Cambridge Healthcare Institute’s Pep Talk 2025

Also giving an in-session talk titled "Modular Multispecific Biotherapeutics: Rapid Therapeutic Design with the ADAPTIR® Platform," showcasing Aptevo's drug engineering…

1 year ago

Intuitive Announces Preliminary Fourth Quarter and Full Year 2024 Results

SUNNYVALE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive…

1 year ago

MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use

HALIFAX, NS / ACCESSWIRE / January 14, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today…

1 year ago